205 related articles for article (PubMed ID: 24253237)
1. Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease.
Nagata T; Kobayashi N; Shinagawa S; Yamada H; Kondo K; Nakayama K
J Neural Transm (Vienna); 2014 Apr; 121(4):433-41. PubMed ID: 24253237
[TBL] [Abstract][Full Text] [Related]
2. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
[TBL] [Abstract][Full Text] [Related]
3. Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.
Nagata T; Shinagawa S; Nukariya K; Yamada H; Nakayama K
Dement Geriatr Cogn Disord; 2012; 33(4):266-72. PubMed ID: 22699449
[TBL] [Abstract][Full Text] [Related]
4. Val66Met polymorphism and BDNF levels in Alzheimer's disease patients in North Indian population.
Sonali N; Tripathi M; Sagar R; Vivekanandhan S
Int J Neurosci; 2013 Jun; 123(6):409-16. PubMed ID: 23270505
[TBL] [Abstract][Full Text] [Related]
5. [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment].
Yu H; Zhang ZJ; Shi YM; Bai F; Qian Y; Yuan YG; Deng LL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):321-5. PubMed ID: 18460776
[TBL] [Abstract][Full Text] [Related]
6. The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.
Bessi V; Mazzeo S; Bagnoli S; Padiglioni S; Carraro M; Piaceri I; Bracco L; Sorbi S; Nacmias B
Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):471-482. PubMed ID: 31560105
[TBL] [Abstract][Full Text] [Related]
7. The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease.
Chuu JY; Taylor JL; Tinklenberg J; Noda A; Yesavage J; Murphy GM
J Alzheimers Dis; 2006 Mar; 9(1):43-9. PubMed ID: 16627933
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
Xie B; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
J Alzheimers Dis; 2017; 58(1):263-274. PubMed ID: 28387675
[TBL] [Abstract][Full Text] [Related]
9. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
10. Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.
Alvarez A; Aleixandre M; Linares C; Masliah E; Moessler H
J Alzheimers Dis; 2014; 42(4):1347-55. PubMed ID: 25024337
[TBL] [Abstract][Full Text] [Related]
11. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han.
Yu H; Zhang Z; Shi Y; Bai F; Xie C; Qian Y; Yuan Y; Deng L
J Clin Psychiatry; 2008 Jul; 69(7):1104-11. PubMed ID: 18505307
[TBL] [Abstract][Full Text] [Related]
12. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington KD; Bourgeat P; Salvado O; Darby D; Snyder PJ; Bush AI; Martins RN; Masters CL; Rowe CC; Nathan PJ; Maruff P;
Neurobiol Aging; 2013 Nov; 34(11):2457-64. PubMed ID: 23769397
[TBL] [Abstract][Full Text] [Related]
13. BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects.
Minelli A; Zanardini R; Bonvicini C; Sartori R; Pedrini L; Gennarelli M; Bocchio-Chiavetto L
Eur Arch Psychiatry Clin Neurosci; 2011 Aug; 261(5):323-9. PubMed ID: 21290143
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
[TBL] [Abstract][Full Text] [Related]
15. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
[TBL] [Abstract][Full Text] [Related]
16. Physical exercise improves peripheral BDNF levels and cognitive functions in mild cognitive impairment elderly with different bdnf Val66Met genotypes.
Nascimento CM; Pereira JR; Pires de Andrade L; Garuffi M; Ayan C; Kerr DS; Talib LL; Cominetti MR; Stella F
J Alzheimers Dis; 2015; 43(1):81-91. PubMed ID: 25062900
[TBL] [Abstract][Full Text] [Related]
17. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
19. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.
Liu J; Yang W; Luo H; Ma Y; Zhao H; Dan X
Aging Clin Exp Res; 2021 Jun; 33(6):1659-1666. PubMed ID: 32892314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
